- Home
- HOTH vs GNTA Comparison
HOTH vs GNTA Comparison
Compare HOTH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOTH | GNTA |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 19.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOTH | GNTA |
|---|---|---|
| Price | $0.79 | $0.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 51.5K |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $0.59 |
| 52 Week High | $2.12 | $10.00 |
Technical Indicators
Market Signals| Indicator | HOTH | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 47.81 |
| Support Level | $0.75 | $0.71 |
| Resistance Level | $1.12 | $0.75 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 98.60 | 65.70 |
Price Performance
Historical ComparisonAbout HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.